A double-blind, placebo-controlled study using Celadrin cream (with no menthol) for the treatment of psoriasis was performed over 14 days. Patients were asked to apply the cream to the affected area twice a day. Initial severity of skin scales, patchiness, redness, dryness, crack and raised skin were recorded. Then, after seven and 14 days, each patient visited the dermatologist who evaluated skin improvement. Each patient experienced a two level improvement based on the six-point Liker scale (0=no improvement, 5 = significant improvement). This small pilot study found that those persons using Celadrin cream experienced measurable improvement in their psoriatic condition.
Psoriasis is a difficult inflammatory skin condition to treat. We can use this data to help those with eczema and other skin conditions halt inflammation and heal the skin.